Sex-specific risk of cardiovascular disease and cognitive decline

Pregnancy and menopause

Virginia M. Miller, Vesna D. Garovic, Kejal Kantarci, Jill N. Barnes, Muthuvel Jayachandran, Michelle M. Mielke, Michael J. Joyner, Lynne T. Shuster, Walter A. Rocca

Research output: Contribution to journalArticle

Abstract

Understanding the biology of sex differences is integral to personalized medicine. Cardiovascular disease and cognitive decline are two related conditions, with distinct sex differences in morbidity and clinical manifestations, response to treatments, and mortality. Although mortality from all-cause cardiovascular diseases has declined in women over the past five years, due in part to increased educational campaigns regarding the recognition of symptoms and application of treatment guidelines, the mortality in women still exceeds that of men. The physiological basis for these differences requires further research, with particular attention to two physiological conditions which are unique to women and associated with hormonal changes: pregnancy and menopause. Both conditions have the potential to impact life-long cardiovascular risk, including cerebrovascular function and cognition in women. This review draws on epidemiological, translational, clinical, and basic science studies to assess the impact of hypertensive pregnancy disorders on cardiovascular disease and cognitive function later in life, and examines the effects of post-menopausal hormone treatments on cardiovascular risk and cognition in midlife women. We suggest that hypertensive pregnancy disorders and menopause activate vascular components, i.e., vascular endothelium and blood elements, including platelets and leukocytes, to release cell-membrane derived microvesicles that are potential mediators of changes in cerebral blood flow, and may ultimately affect cognition in women as they age. Research into specific sex differences for these disease processes with attention to an individual's sex chromosomal complement and hormonal status is important and timely.

Original languageEnglish (US)
Article number6
JournalBiology of Sex Differences
Volume4
Issue number1
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

menopause
Menopause
pregnancy
Cardiovascular Diseases
Disease
Pregnancy
Cognition
Sex Characteristics
cognition
mortality
Mortality
Cerebrovascular Circulation
Precision Medicine
Vascular Endothelium
science studies
Research
morbidity
Blood Vessels
Cognitive Dysfunction
biology

Keywords

  • Brain imaging
  • Cerebral blood flow
  • Cognition
  • Estrogen
  • Hormone
  • Hypertension
  • Microvesicles
  • Preeclampsia
  • White matter hyperintensities

ASJC Scopus subject areas

  • Endocrinology
  • Gender Studies

Cite this

Miller, V. M., Garovic, V. D., Kantarci, K., Barnes, J. N., Jayachandran, M., Mielke, M. M., ... Rocca, W. A. (2013). Sex-specific risk of cardiovascular disease and cognitive decline: Pregnancy and menopause. Biology of Sex Differences, 4(1), [6]. https://doi.org/10.1186/2042-6410-4-6

Sex-specific risk of cardiovascular disease and cognitive decline : Pregnancy and menopause. / Miller, Virginia M.; Garovic, Vesna D.; Kantarci, Kejal; Barnes, Jill N.; Jayachandran, Muthuvel; Mielke, Michelle M.; Joyner, Michael J.; Shuster, Lynne T.; Rocca, Walter A.

In: Biology of Sex Differences, Vol. 4, No. 1, 6, 2013.

Research output: Contribution to journalArticle

Miller, VM, Garovic, VD, Kantarci, K, Barnes, JN, Jayachandran, M, Mielke, MM, Joyner, MJ, Shuster, LT & Rocca, WA 2013, 'Sex-specific risk of cardiovascular disease and cognitive decline: Pregnancy and menopause', Biology of Sex Differences, vol. 4, no. 1, 6. https://doi.org/10.1186/2042-6410-4-6
Miller, Virginia M. ; Garovic, Vesna D. ; Kantarci, Kejal ; Barnes, Jill N. ; Jayachandran, Muthuvel ; Mielke, Michelle M. ; Joyner, Michael J. ; Shuster, Lynne T. ; Rocca, Walter A. / Sex-specific risk of cardiovascular disease and cognitive decline : Pregnancy and menopause. In: Biology of Sex Differences. 2013 ; Vol. 4, No. 1.
@article{4e3f8916e662402cb1b803c1c323b918,
title = "Sex-specific risk of cardiovascular disease and cognitive decline: Pregnancy and menopause",
abstract = "Understanding the biology of sex differences is integral to personalized medicine. Cardiovascular disease and cognitive decline are two related conditions, with distinct sex differences in morbidity and clinical manifestations, response to treatments, and mortality. Although mortality from all-cause cardiovascular diseases has declined in women over the past five years, due in part to increased educational campaigns regarding the recognition of symptoms and application of treatment guidelines, the mortality in women still exceeds that of men. The physiological basis for these differences requires further research, with particular attention to two physiological conditions which are unique to women and associated with hormonal changes: pregnancy and menopause. Both conditions have the potential to impact life-long cardiovascular risk, including cerebrovascular function and cognition in women. This review draws on epidemiological, translational, clinical, and basic science studies to assess the impact of hypertensive pregnancy disorders on cardiovascular disease and cognitive function later in life, and examines the effects of post-menopausal hormone treatments on cardiovascular risk and cognition in midlife women. We suggest that hypertensive pregnancy disorders and menopause activate vascular components, i.e., vascular endothelium and blood elements, including platelets and leukocytes, to release cell-membrane derived microvesicles that are potential mediators of changes in cerebral blood flow, and may ultimately affect cognition in women as they age. Research into specific sex differences for these disease processes with attention to an individual's sex chromosomal complement and hormonal status is important and timely.",
keywords = "Brain imaging, Cerebral blood flow, Cognition, Estrogen, Hormone, Hypertension, Microvesicles, Preeclampsia, White matter hyperintensities",
author = "Miller, {Virginia M.} and Garovic, {Vesna D.} and Kejal Kantarci and Barnes, {Jill N.} and Muthuvel Jayachandran and Mielke, {Michelle M.} and Joyner, {Michael J.} and Shuster, {Lynne T.} and Rocca, {Walter A.}",
year = "2013",
doi = "10.1186/2042-6410-4-6",
language = "English (US)",
volume = "4",
journal = "Biology of Sex Differences",
issn = "2042-6410",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Sex-specific risk of cardiovascular disease and cognitive decline

T2 - Pregnancy and menopause

AU - Miller, Virginia M.

AU - Garovic, Vesna D.

AU - Kantarci, Kejal

AU - Barnes, Jill N.

AU - Jayachandran, Muthuvel

AU - Mielke, Michelle M.

AU - Joyner, Michael J.

AU - Shuster, Lynne T.

AU - Rocca, Walter A.

PY - 2013

Y1 - 2013

N2 - Understanding the biology of sex differences is integral to personalized medicine. Cardiovascular disease and cognitive decline are two related conditions, with distinct sex differences in morbidity and clinical manifestations, response to treatments, and mortality. Although mortality from all-cause cardiovascular diseases has declined in women over the past five years, due in part to increased educational campaigns regarding the recognition of symptoms and application of treatment guidelines, the mortality in women still exceeds that of men. The physiological basis for these differences requires further research, with particular attention to two physiological conditions which are unique to women and associated with hormonal changes: pregnancy and menopause. Both conditions have the potential to impact life-long cardiovascular risk, including cerebrovascular function and cognition in women. This review draws on epidemiological, translational, clinical, and basic science studies to assess the impact of hypertensive pregnancy disorders on cardiovascular disease and cognitive function later in life, and examines the effects of post-menopausal hormone treatments on cardiovascular risk and cognition in midlife women. We suggest that hypertensive pregnancy disorders and menopause activate vascular components, i.e., vascular endothelium and blood elements, including platelets and leukocytes, to release cell-membrane derived microvesicles that are potential mediators of changes in cerebral blood flow, and may ultimately affect cognition in women as they age. Research into specific sex differences for these disease processes with attention to an individual's sex chromosomal complement and hormonal status is important and timely.

AB - Understanding the biology of sex differences is integral to personalized medicine. Cardiovascular disease and cognitive decline are two related conditions, with distinct sex differences in morbidity and clinical manifestations, response to treatments, and mortality. Although mortality from all-cause cardiovascular diseases has declined in women over the past five years, due in part to increased educational campaigns regarding the recognition of symptoms and application of treatment guidelines, the mortality in women still exceeds that of men. The physiological basis for these differences requires further research, with particular attention to two physiological conditions which are unique to women and associated with hormonal changes: pregnancy and menopause. Both conditions have the potential to impact life-long cardiovascular risk, including cerebrovascular function and cognition in women. This review draws on epidemiological, translational, clinical, and basic science studies to assess the impact of hypertensive pregnancy disorders on cardiovascular disease and cognitive function later in life, and examines the effects of post-menopausal hormone treatments on cardiovascular risk and cognition in midlife women. We suggest that hypertensive pregnancy disorders and menopause activate vascular components, i.e., vascular endothelium and blood elements, including platelets and leukocytes, to release cell-membrane derived microvesicles that are potential mediators of changes in cerebral blood flow, and may ultimately affect cognition in women as they age. Research into specific sex differences for these disease processes with attention to an individual's sex chromosomal complement and hormonal status is important and timely.

KW - Brain imaging

KW - Cerebral blood flow

KW - Cognition

KW - Estrogen

KW - Hormone

KW - Hypertension

KW - Microvesicles

KW - Preeclampsia

KW - White matter hyperintensities

UR - http://www.scopus.com/inward/record.url?scp=84892943167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892943167&partnerID=8YFLogxK

U2 - 10.1186/2042-6410-4-6

DO - 10.1186/2042-6410-4-6

M3 - Article

VL - 4

JO - Biology of Sex Differences

JF - Biology of Sex Differences

SN - 2042-6410

IS - 1

M1 - 6

ER -